Importantly, to avoid effects associated with the most acknowledged genetic susceptibility factors, and to obtain data on new pathological mechanisms, we used MSCs derived only from PSP patients screened against the MAPT H1 haplotype. Here, MAPT is linked to supranuclear palsy, progressive, 1.